June, 2023 - Microbiome Times Magazine

Seres Therapeutics and Nestlé Health Science Announce U.S. Commercial Availability Of Vowst™

June 5, 2023 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB) and Nestlé Health Science today announced that VOWST™ (fecal microbiota spores, live-brpk) is now commercially available for patients. VOWST, formerly called SER-109, is the first and only U.S. Food and Drug […]

Ilya Pharma’s genetically modified lactic acid bacteria drug candidate effectively accelerates wound healing in clinical study

June 1, 2023 Microbiome Times

Complicated, hard-to-heal wounds are a growing medical problem and there are currently only two drugs approved with proven efficacy. In a new study on humans, researchers at Uppsala University show that treatment with a specific […]